A quantitative measure of the 
effect of your therapy

The OcuMet Beacon™ is designed to provide patientspecific measurements to quantify the effect of therapeutic interventions, leading to customized patient plans and/or validating therapy development with Retinal Metabolic Analysis (RMA™). Using flavoprotein fluorescence (FPF), it is possible to investigate a line of inquiry across several levels: from rapid compound screening, drug discovery, and ultimately, to patient care.

Interested in working together?